Elliot Haddock

Global Commercial Director, Launch Products Mundipharma

Elliot brings over 15 years of experience across commercial and supply chain roles, beginning his career as an Officer in the Royal Air Force. He transitioned to the pharmaceutical industry nine years ago, where he has since held a range of leadership positions at both regional and country levels. Most recently, Elliot served as General Manager for South Africa and Sub-Saharan Africa.

Now based in the UK, Elliot is part of the Global team at Mundipharma, where he is focused on their first Global Anti-Infectives product launch. His diverse experience spans in launch and portfolio optimisation spans multiple therapy areas, including Pain, Substitution Therapy, Respiratory, Ophthalmology, Anti-Infectives, and Orphan Drugs.

Elliot is known for his pragmatic and agile leadership style, with a strong emphasis on translating strategy into executional excellence.

Pharma Launch Excellence Summit Main Conference Day 2: Wednesday 3rd December

12:00 PM Panel Discussion: Cross-Functional Leadership Success Stories - From Alignment to Acceleration

Hear from leaders across commercial, forecasting, medical, access, and product on how they’ve navigated cohesion, resolved conflict, and built launch momentum through empowered collaboration.

· Aligning priorities across departments without compromising function-specific objectives

· Navigating tension between speed, compliance, and long-term launch value

· Foster psychological safety for better communication and faster issue resolution

Leave with insights into driving alignment without friction across diverse launch stakeholders.

2:30 PM Presentation/Case Study: From Traditional to Speciality - Navigating the Transition to an Orphan Drug Launch

As the Global Commercial Director of Launch Readiness at Mundipharma, Elliot will share practical insights from launching REZZAYO® (rezafungin) - the company's entry into speciality care and the orphan drug space. Learn how a mid-sized pharma navigated new territory with their first global launch of a hospital-based speciality care product in a disease area with no new launches for 10+ years.

Speciality launch challenges: Overcoming the learning curve when transitioning from traditional to specialty/orphan drug models
Value differentiation: Making the most of multi-layered patient focussed commercialisation in markets with established generic competition
Geographical Expansion: Deciding where to focus resources to maximise launch potential and support the unmet patient need
Learning to grow: How to adapt through successes and set-backs to optimise for the future

Check out the incredible speaker line-up to see who will be joining Elliot.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk